Emily Belowich

Emily Belowich supports clients across the healthcare system seeking to optimize payment and care-delivery strategies as they adapt their business models toward value-based environments.

She applies her background in quality improvement to support clients in work involving patient engagement, digital health, and strategic planning.

Prior to joining Avalere, Emily was a research consultant with The Lewin Group, where she collaborated with clinicians, administrators, quality improvement advisers, and patients to design and implement a national practice transformation program aimed at supporting clinicians in entering advanced payment models.

Emily has a BA from the Health: Science, Society, and Policy program at Brandeis University.

Authored Content

Tune in to hear the final episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 3, we’ll be focusing on the End Stage Renal Disease (ESRD) Prospective Payment System, with a focus on proposed payment changes for innovative drugs, supplies, and equipment and updates to the Quality Incentive Program (QIP).

It is no surprise that innovation in the world of digital health is transforming the way healthcare is delivered.

The Centers for Medicare & Medicaid Services (CMS) is embracing digital health and virtual care in many ways.

In early February, Avalere attended the annual Centers for Medicare & Medicaid Services (CMS) Quality Conference, an annual gathering that brings stakeholders together to address challenges in healthcare quality improvement and discuss ways to spread these solutions locally and nationally.